Literature DB >> 30905581

Assessment of stability and fluctuations of cultured lower airway bacterial communities in people with cystic fibrosis.

Laura J Sherrard1, Gisli G Einarsson2, Elinor Johnston2, Katherine O'Neill2, Leanne McIlreavey2, Stephanie J McGrath3, Deirdre F Gilpin3, Damian G Downey4, Alastair Reid5, Noel G McElvaney6, Richard C Boucher7, Marianne S Muhlebach8, J Stuart Elborn9, Michael M Tunney3.   

Abstract

BACKGROUND: Routine clinical culture detects a subset of the cystic fibrosis (CF) airways microbiota based on culture-independent (molecular) methods. This study aimed to determine how extended sputum culture of viable bacteria changes over time in relation to clinical status and predicts exacerbations.
METHODS: Sputa from patients at a baseline stable and up to three subsequent time-points were analysed by extended-quantitative culture; aerobe/anaerobe densities, ecological indexes and community structure were assessed together with clinical outcomes.
RESULTS: Eighty patients were prospectively recruited. Sputa were successfully collected and cultured at 199/267 (74.5%) study visits. Eighty-two sputa from 25 patients comprised a complete sample-set for longitudinal analyses. Bacterial density, ecological indexes and clinical outcomes were unchanged in 18 patients with three sequential stable visits. Conversely, in 7 patients who had an exacerbation, total bacterial and aerobe densities differed over four study visits (P < .001) with this difference particularly apparent between the baseline visit and completion of acute antibiotic treatment where a decrease in density was observed. Bacterial communities were more similar within than between patients but stable patients had the least variation in community structure over time. Using logistic regression in a further analysis, baseline features in 37 patients without compared to 15 patients with a subsequent exacerbation showed that clinical measures rather than bacterial density or ecological indexes were independent predictors of an exacerbation.
CONCLUSIONS: Greater fluctuation in the viable bacterial community during treatment of an exacerbation than between stable visits was observed. Extended-quantitative culture did not provide prognostic information of a future exacerbation.
Copyright © 2019 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bacterial density; Bacterial ecology; Extended-quantitative culture; Sputum

Mesh:

Substances:

Year:  2019        PMID: 30905581      PMCID: PMC6754815          DOI: 10.1016/j.jcf.2019.02.012

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  28 in total

1.  Standardisation of spirometry.

Authors:  M R Miller; J Hankinson; V Brusasco; F Burgos; R Casaburi; A Coates; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; R Jensen; D C Johnson; N MacIntyre; R McKay; D Navajas; O F Pedersen; R Pellegrino; G Viegi; J Wanger
Journal:  Eur Respir J       Date:  2005-08       Impact factor: 16.671

2.  Decade-long bacterial community dynamics in cystic fibrosis airways.

Authors:  Jiangchao Zhao; Patrick D Schloss; Linda M Kalikin; Lisa A Carmody; Bridget K Foster; Joseph F Petrosino; James D Cavalcoli; Donald R VanDevanter; Susan Murray; Jun Z Li; Vincent B Young; John J LiPuma
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

3.  Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa.

Authors:  Vanja Klepac-Ceraj; Katherine P Lemon; Thomas R Martin; Martin Allgaier; Steven W Kembel; Alixandra A Knapp; Stephen Lory; Eoin L Brodie; Susan V Lynch; Brendan J M Bohannan; Jessica L Green; Brian A Maurer; Roberto Kolter
Journal:  Environ Microbiol       Date:  2010-02-23       Impact factor: 5.491

4.  Development and validation of The Cystic Fibrosis Questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis.

Authors:  Alexandra L Quittner; Anne Buu; Melissa A Messer; Avani C Modi; Marc Watrous
Journal:  Chest       Date:  2005-10       Impact factor: 9.410

5.  Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.

Authors:  Tim W R Lee; Keith G Brownlee; Steven P Conway; Miles Denton; James M Littlewood
Journal:  J Cyst Fibros       Date:  2003-03       Impact factor: 5.482

Review 6.  Cystic fibrosis.

Authors:  J Stuart Elborn
Journal:  Lancet       Date:  2016-04-29       Impact factor: 79.321

7.  Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report.

Authors:  Philip M Farrell; Beryl J Rosenstein; Terry B White; Frank J Accurso; Carlo Castellani; Garry R Cutting; Peter R Durie; Vicky A Legrys; John Massie; Richard B Parad; Michael J Rock; Preston W Campbell
Journal:  J Pediatr       Date:  2008-08       Impact factor: 4.406

8.  The Role of Short-Chain Fatty Acids, Produced by Anaerobic Bacteria, in the Cystic Fibrosis Airway.

Authors:  Bojana Mirković; Michelle A Murray; Gillian M Lavelle; Kevin Molloy; Ahmed Abdul Azim; Cedric Gunaratnam; Fiona Healy; Dubhfeasa Slattery; Paul McNally; Joe Hatch; Matthew Wolfgang; Michael M Tunney; Marianne S Muhlebach; Rosaleen Devery; Catherine M Greene; Noel G McElvaney
Journal:  Am J Respir Crit Care Med       Date:  2015-12-01       Impact factor: 21.405

9.  Reduced bacterial colony count of anaerobic bacteria is associated with a worsening in lung clearance index and inflammation in cystic fibrosis.

Authors:  Katherine O'Neill; Judy M Bradley; Elinor Johnston; Stephanie McGrath; Leanne McIlreavey; Stephen Rowan; Alastair Reid; Ian Bradbury; Gisli Einarsson; J Stuart Elborn; Michael M Tunney
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

10.  Early detection of pulmonary exacerbations in children with Cystic Fibrosis by electronic home monitoring of symptoms and lung function.

Authors:  Marieke van Horck; Bjorn Winkens; Geertjan Wesseling; Dillys van Vliet; Kim van de Kant; Sanne Vaassen; Karin de Winter-de Groot; Ilja de Vreede; Quirijn Jöbsis; Edward Dompeling
Journal:  Sci Rep       Date:  2017-09-27       Impact factor: 4.379

View more
  9 in total

Review 1.  Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease.

Authors:  Claire Healy; Natalia Munoz-Wolf; Janné Strydom; Lynne Faherty; Niamh C Williams; Sarah Kenny; Seamas C Donnelly; Suzanne M Cloonan
Journal:  Respir Res       Date:  2021-04-29

2.  Bioorthogonal non-canonical amino acid tagging reveals translationally active subpopulations of the cystic fibrosis lung microbiota.

Authors:  Talia D Valentini; Sarah K Lucas; Kelsey A Binder; Lydia C Cameron; Jason A Motl; Jordan M Dunitz; Ryan C Hunter
Journal:  Nat Commun       Date:  2020-05-08       Impact factor: 14.919

3.  An observational study of anaerobic bacteria in cystic fibrosis lung using culture dependant and independent approaches.

Authors:  Claudie Lamoureux; Charles-Antoine Guilloux; Clémence Beauruelle; Stéphanie Gouriou; Sophie Ramel; Anne Dirou; Jean Le Bihan; Krista Revert; Thomas Ropars; Rosyne Lagrafeuille; Sophie Vallet; Rozenn Le Berre; Emmanuel Nowak; Geneviève Héry-Arnaud
Journal:  Sci Rep       Date:  2021-03-25       Impact factor: 4.379

4.  Extended Bacteria Culture-Based Clustering Identifies a Phenotype Associating Increased Cough and Enterobacterales in Stable Chronic Obstructive Pulmonary Disease.

Authors:  Anaëlle Muggeo; Jeanne-Marie Perotin; Audrey Brisebarre; Sandra Dury; Valérian Dormoy; Claire Launois; Julien Ancel; Pauline Mulette; Christophe de Champs; Gaëtan Deslée; Thomas Guillard
Journal:  Front Microbiol       Date:  2021-12-14       Impact factor: 5.640

5.  Microbial Community Composition in Explanted Cystic Fibrosis and Control Donor Lungs.

Authors:  Gisli G Einarsson; Bart M Vanaudenaerde; Christopher D Spence; Andrew J Lee; Mieke Boon; Geert M Verleden; J Stuart Elborn; Lieven J Dupont; Dirk Van Raemdonck; Deirdre F Gilpin; Robin Vos; Stijn E Verleden; Michael M Tunney
Journal:  Front Cell Infect Microbiol       Date:  2022-03-16       Impact factor: 5.293

6.  The Nicotinic Receptor Polymorphism rs16969968 Is Associated with Airway Remodeling and Inflammatory Dysregulation in COPD Patients.

Authors:  Lynda Saber Cherif; Zania Diabasana; Jeanne-Marie Perotin; Julien Ancel; Laure M G Petit; Maëva A Devilliers; Arnaud Bonnomet; Nathalie Lalun; Gonzague Delepine; Uwe Maskos; Philippe Gosset; Myriam Polette; Anaëlle Muggeo; Thomas Guillard; Gaëtan Deslée; Valérian Dormoy
Journal:  Cells       Date:  2022-09-20       Impact factor: 7.666

7.  Longitudinal Associations of the Cystic Fibrosis Airway Microbiome and Volatile Metabolites: A Case Study.

Authors:  Andrea Hahn; Katrine Whiteson; Trenton J Davis; Joann Phan; Iman Sami; Anastassios C Koumbourlis; Robert J Freishtat; Keith A Crandall; Heather D Bean
Journal:  Front Cell Infect Microbiol       Date:  2020-04-28       Impact factor: 5.293

Review 8.  The Open Challenge of in vitro Modeling Complex and Multi-Microbial Communities in Three-Dimensional Niches.

Authors:  Martina Oriano; Laura Zorzetto; Giuseppe Guagliano; Federico Bertoglio; Sebastião van Uden; Livia Visai; Paola Petrini
Journal:  Front Bioeng Biotechnol       Date:  2020-10-20

9.  Mild Cystic Fibrosis Lung Disease Is Associated with Bacterial Community Stability.

Authors:  Thomas H Hampton; Devin Thomas; Christopher van der Gast; George A O'Toole; Bruce A Stanton
Journal:  Microbiol Spectr       Date:  2021-07-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.